Transforming childhood cancer research

We’re transforming how childhood cancer research is funded and delivered in Australia — uniting government, philanthropy, researchers, clinicians, advocates, survivors and families to accelerate breakthrough discoveries and create a future where every child with cancer can survive and thrive.

Our team

The people behind our mission

As an independent non-profit, we’ve united many of Australia’s brightest minds in childhood cancer research and innovation. Unlike traditional research funders, we take a bold approach to accomplish what no single organisation can achieve in isolation. Together, we’re delivering real-world, transformative impact for our youngest cancer patients.

Our Experts

Scientific rigour and lived experience guide every funding decision, ensuring the research we support has the potential to create real-world change.

Our Partners

We unite government, philanthropy, researchers, clinicians, advocates, survivors and families, backed by substantial support from our major partners, to accelerate breakthrough discoveries.

Our Major Partners

Our Research Partners

Advancing research through collaboration

For too many Australian children and their families, a cancer diagnosis is devastating, and the research needed to improve their outcomes has been held back by siloed efforts and institutional constraints. Children's Cancer CoLab exists to break down those barriers. As an independent non-profit, we fund research based on scientific merit and real-world impact, because every child who faces cancer deserves to survive and thrive.

1,000

Australian children and adolescents are diagnosed with cancer every year

3

children die every week from cancer

1 in 5

children diagnosed with cancer do not survive

80%

of children who survive cancer have long-term effects from their treatment

70

potential years of life are lost when a child dies from cancer

400,000

new cases of cancer are diagnosed worldwide every year in children and adolescents

Contact us

We’re improving outcomes for our youngest cancer patients by accelerating research, innovation and collaboration.